Deepak Fertilisers & Petrochemicals Corp Ltd Q3 FY2025 Concall Summary

Key Takeaways

• Broad-based volume surge, margin expansion: Consolidated revenue rose 39% and EBITDA 72% YoY, with EBITDA margin expanding 362 bps, driven by peak capacity utilization and an optimized business mix.
• Backward integration paying off: The world-scale ammonia plant is stabilizing at higher levels, contributing significantly to EBITDA at current prices and providing a structural cost advantage across the product chain.
• Restructuring unlocks focus: The demerger is complete, placing each business in an independent entity with dedicated leadership, explicitly targeting a shift from commodity to specialty.
• Capex cycle peak approaching: Two major capacity expansion projects are on track for H2 FY26 commissioning, with peak net debt of ~₹5,500 crores expected around the same time before cash generation kicks in.
• What to watch next quarter: The definitive commissioning timeline for the Dahej and Gopalpur plants, the trajectory of specialty mix improvement beyond the current 20% share, and any sustained pricing pressure in the nitric acid chain from cheap imports.

Volume-Led Performance & Margin Drivers

• Operational excellence unlocked capacity: Cross-functional teams attacking downtime, preventive maintenance, and smart factory initiatives pushed capacity utilization to 85–105%, making the business more supply-constrained than demand-constrained.
• IT-driven allocation optimized mix: A new S&OP system created a closed loop from raw material coordination through marketing, enabling allocation of inputs to the best possible end use and directly supporting the 362 bps margin expansion.
• Ammonia plant delivered structural advantage: At \$400+ ammonia prices, the backward-integrated plant contributed significantly to EBITDA; management noted it is near breakeven at the PBT level, insulating downstream margins.
• Natural hedge across businesses: The portfolio is structured so that as one business enters its off-season, another runs through peak season, allowing consolidated profitability to hold steady through the year.

Anand: "There is a natural hedge between these businesses, where one business when it goes towards off-season, other business running through a peak season. So, at an overall level, we can hold on to our overall profitability at a consol level."

Business Segment Performance

• Specialty shift protecting CNB margins: The focus on crop-specific, value-added fertilizers is expanding margins every quarter, even as overall volumes fluctuate; management intends to continue this journey.
• Semiconductor and solar-grade chemicals: In-house capability is developed and business has started over the last couple of quarters, currently contributing a single-digit share to industrial chemicals; management expects it to become a reportable contributor in a couple of years.

Capex Cycle & Balance Sheet

• Two projects nearing completion: A nitric acid plant at Dahej and a TAN plant at Gopalpur, Odisha, are expected to start production in H2 FY26; a definitive quarter or month has not yet been set.
• Peak debt and the turn: Net debt will peak around ₹5,500 crores towards H2 FY26 when both projects are completed; once operational, cash generation will begin impairing debt, described as a temporary phenomenon.
• Equinor LNG supply locked in: Gas supply starts Q1 FY27 and will cover the entire requirement, with management quantifying the cost reduction at 20% plus versus current sourcing after an analyst follow-up.
• Ammonia sourcing for new plants: Importing ammonia directly to the east coast Gopalpur plant is commercially more beneficial than shipping from Taloja; all options remain open.
• Project IRRs: Management expects returns in the high teens on the new capacity.

Anand: "In fact, the capacity, which is coming up in eastern coast, it's much beneficial if we import and utilize that ammonia rather than shipping from Taloja to those locations."

Specialty Transformation & Strategy

• The stated ambition: Move the portfolio from commodity to specialty, growing the current ~20% specialty revenue share to a larger number, with a 5-year roadmap under discussion.
• Growth levers before new capex: Customer segmentation, selling into more profitable geographies and applications, and moving downstream into the value chain (e.g., cartridge-based explosives for mining clients, currently in concept testing).
• Croptek volumes holding: Management expects to maintain around the 60,000 level in Q4, with some fluctuations expected given the non-quarterly nature of the business.
• IPA specialty exploration underway: Opportunities for more specialty grades are being evaluated; no timeline committed until a solid value-addition case is clear.

Mehta: "The clearest growth strategy has to be doing more of the same."

Restructuring & Organizational Focus

• Demerger technically complete: All three entities (MAL and DMSL) are now independent with focused boards and officers, though they remain subsidiaries under DFPCL as the parent.
• Focus unlocked: Management credits the restructuring with enabling each business to concentrate on its key strategic levers and the shift from commodity to specialty, free of cross-business distraction.
• Non-core asset monetization: The Pune mall sale remains under discussion with no conclusion reached; management will update the market once a decision point arrives.

Anand: "Good thing which has happened with this restructuring, since all entities are now independent, each business is highly focused on their key strategic levers, how do they take their business to the next level and how do they move from commodity to specialty."

Guidance & Commitments

Key Metrics